These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18668117)

  • 1. Clinical practice guidelines for supplemental therapies and issues.
    Klarenbach SW; Moist LM; Foley RN; Barrett BJ; Madore F; White CT; Culleton BF; Tonelli M; Manns BJ;
    Kidney Int Suppl; 2008 Aug; (110):S19-24. PubMed ID: 18668117
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical practice guidelines for evidence-based use of erythropoietic-stimulating agents.
    Moist LM; Foley RN; Barrett BJ; Madore F; White CT; Klarenbach SW; Culleton BF; Tonelli M; Manns BJ;
    Kidney Int Suppl; 2008 Aug; (110):S12-8. PubMed ID: 18668116
    [No Abstract]   [Full Text] [Related]  

  • 3. Introduction to the Canadian Society of Nephrology clinical practice guidelines for the management of anemia associated with chronic kidney disease.
    Manns BJ; White CT; Madore F; Moist LM; Klarenbach SW; Barrett BJ; Foley RN; Culleton BF; Tonelli M
    Kidney Int Suppl; 2008 Aug; (110):S1-3. PubMed ID: 18668115
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical practice guidelines for assessment and management of iron deficiency.
    Madore F; White CT; Foley RN; Barrett BJ; Moist LM; Klarenbach SW; Culleton BF; Tonelli M; Manns BJ;
    Kidney Int Suppl; 2008 Aug; (110):S7-S11. PubMed ID: 18668119
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidemic of iron overload in dialysis population caused by intravenous iron products: a plea for moderation.
    Vaziri ND
    Am J Med; 2012 Oct; 125(10):951-2. PubMed ID: 22795817
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA approval of Omontys changes the ESA playing field.
    Neumann ME
    Nephrol News Issues; 2012 May; 26(6):17. PubMed ID: 22690453
    [No Abstract]   [Full Text] [Related]  

  • 7. Epoetin bubble: a severe German case Honi soit qui mal y pense.
    Wizemann V
    Nephrol Dial Transplant; 2011 May; 26(5):1750-2; author reply 1752. PubMed ID: 21378149
    [No Abstract]   [Full Text] [Related]  

  • 8. Revised European Best Practice Guidelines for the management of anaemia in patients with chronic renal failure, part III.2: treatment of anaemia with iron.
    Vaage-Nilsen O
    Nephrol Dial Transplant; 2005 Jul; 20(7):1512-3; author reply 1513-4. PubMed ID: 15967789
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemoglobin variability in dialysis patients.
    Brimble KS; Clase CM
    J Am Soc Nephrol; 2007 Aug; 18(8):2218-20. PubMed ID: 17627931
    [No Abstract]   [Full Text] [Related]  

  • 10. Relative mortality and epoetin alpha dose in hemodialysis patients.
    Cotter DJ; Thamer M; Zhang Y
    Am J Kidney Dis; 2008 May; 51(5):865; author reply 865-6. PubMed ID: 18436099
    [No Abstract]   [Full Text] [Related]  

  • 11. Relative mortality and epoetin alpha dose among hemodialysis patients.
    Coyne DW
    Am J Kidney Dis; 2008 May; 51(5):866-7; author reply 867. PubMed ID: 18436101
    [No Abstract]   [Full Text] [Related]  

  • 12. Update on clinical practice recommendations and new therapeutic modalities for treating anemia in patients with chronic kidney disease.
    Grabe DW
    Am J Health Syst Pharm; 2007 Jul; 64(13 Suppl 8):S8-14; quiz S23-5. PubMed ID: 17591995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of anemia in patients with chronic renal disease: is it time for self-criticism?].
    Del Vecchio L
    G Ital Nefrol; 2007; 24(4):285. PubMed ID: 17659497
    [No Abstract]   [Full Text] [Related]  

  • 14. Internal medicine, renal anaemia, and erythropoiesis-stimulating agents (ESAS).
    Veys N; Van Biesen W; Lameire N
    Acta Clin Belg; 2007; 62(6):396-407. PubMed ID: 18351184
    [No Abstract]   [Full Text] [Related]  

  • 15. Correcting iron-restricted erythropoiesis and improving anemia in patients on hemodialysis: practical tips that can make a difference.
    Easom A
    Nephrol Nurs J; 2009; 36(5):529-37, 553. PubMed ID: 19856814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applying evidence into routine clinical care at a unit level: the exemplar of renal anaemia management.
    Gallagher MP; Cass A; Craig JC
    Nephrology (Carlton); 2010 Jun; 15(4):429-33. PubMed ID: 20609094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anemia of chronic kidney disease and end-stage renal disease: are there unique issues in disadvantaged populations?
    Obrador GT
    Ethn Dis; 2009; 19(1 Suppl 1):S1-52-5. PubMed ID: 19484876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction to "A road map for intravenous iron and anemia management: preparing for the future".
    Coyne DW
    Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S1-4. PubMed ID: 19010256
    [No Abstract]   [Full Text] [Related]  

  • 20. Recovery room care of the patient with renal disease.
    Levine RD
    Int Anesthesiol Clin; 1983; 21(1):185-98. PubMed ID: 6343252
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.